Skip to main content Back to Top
Advertisement

3/30/2024

Amphetamine Mixed Salts, Immediate-Release Tablets

Products Affected - Description

    • Amphetamine mixed salts immediate release tablet, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0176-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 15 mg, bottle, 100 count, NDC 47781-0178-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 20 mg, bottle, 100 count, NDC 47781-0179-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 30 mg, bottle, 100 count, NDC 47781-0180-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 5 mg, bottle, 100 count, NDC 47781-0174-01
    • Amphetamine mixed salts immediate release tablet, Camber, 10 mg, bottle, 100 count, NDC 31722-0157-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 12.5 mg, bottle, 100 count, NDC 31722-0158-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 15 mg, bottle, 100 count, NDC 31722-0159-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 20 mg, bottle, 100 count, NDC 31722-0163-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 30 mg, bottle, 100 count, NDC 31722-0164-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 5 mg, bottle, 100 count, NDC 31722-0155-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 7.5 mg, bottle, 100 count, NDC 31722-0156-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 10 mg, bottle, 100 count, NDC 00527-1502-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 12.5 mg, bottle, 100 count, NDC 00527-1503-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 15 mg, bottle, 100 count, NDC 00527-1504-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-1505-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 30 mg, bottle, 100 count, NDC 00527-1506-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 5 mg, bottle, 100 count, NDC 00527-1500-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Lannett, 7.5 mg, bottle, 100 count, NDC 00527-1501-37 - discontinued
    • Amphetamine mixed salts immediate release tablet, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0723-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 12.5 mg, bottle, 100 count, NDC 42858-0724-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0725-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0726-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0727-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 5 mg, bottle, 100 count, NDC 42858-0721-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 7.5 mg, bottle, 100 count, NDC 42858-0722-01
    • Amphetamine mixed salts immediate release tablet, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0458-10 - discontinued
    • Amphetamine mixed salts immediate release tablet, Solco Healthcare US, 5 mg, bottle, 100 count, NDC 43547-0457-10 - discontinued
    • Amphetamine mixed salts immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 00555-0972-02
    • Amphetamine mixed salts immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 00555-0973-02
    • Amphetamine mixed salts immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 00555-0971-02

Reason for the Shortage

    • Alvogen did not provide a reason for the shortage.
    • Aurobindo refuses to provide availability information.
    • Camber discontinued amphetamine mixed salts immediate-release tablets.
    • Lannett discontinued amphetamine mixed salts immediate-release tablets.
    • Mallincrodt refuses to provide availability information.
    • Rhodes did not provide a reason for the shortage.
    • Sandoz has amphetamine mixed salts immediate-release tablets available.
    • Solco discontinued amphetamine mixed salts immediate-release tablets.
    • Teva did not provide a reason for the shortage.
    • Mylan and Zydus have discontinued amphetamine mixed salt immediate-release tablets.

Available Products

    • Adderall immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 57844-0110-01
    • Adderall immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 57844-0112-01
    • Adderall immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 57844-0115-01
    • Adderall immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 57844-0120-01
    • Adderall immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 57844-0130-01
    • Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01
    • Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 10 mg, bottle, 100 count, NDC 00185-0842-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 20 mg, bottle, 100 count, NDC 00185-0853-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 30 mg, bottle, 100 count, NDC 00185-2099-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 5 mg, bottle, 100 count, NDC 00185-2098-01
    • Amphetamine mixed salts immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 00555-0776-02
    • Amphetamine mixed salts immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 00555-0777-02
    • Amphetamine mixed salts immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 00555-0974-02
    • Amphetamine mixed salts immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 00555-0775-02

Estimated Resupply Dates

    • Alvogen has all presentations in limited supply or on intermittent back order and the company is releasing supplies as they become available.
    • Rhodes has all presentations on back order and the company cannot estimate a release date.
    • Teva has amphetamine mixed salts 5 mg, 10 mg, and 20 mg immediate-release tablets on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated March 30, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created July 27, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT